“Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis.” Bridget F. Collins and Ganesh Raghu. Eur Respir Rev 2019; 28: 190022.

Ejemplares similares

• “The therapy of idiopathic pulmonary fibrosis: what is next?” Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi, et al. Eur Respir Rev 2019; 28: 190021.
  Publicado: (2019)
• “Immune mechanisms in fibrotic pulmonary sarcoidosis”. P. Weeratunga, D.R. Moller and L-P. Ho. Eur Respir Rev 2022; 31: 220178
  Publicado: (2023)
• “Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.” Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58–64.
  Publicado: (2015)
• “Intersections of lung progenitor cells, lung disease and lung cancer.” Carla F. Kim. Eur Respir Rev 2017; 26: 170054.
  Publicado: (2017)
• “Is bronchiectasis really a disease?” Michal Shteinberg, Patrick A. Flume and James D. Chalmers. Eur Respir Rev 2020; 29: 190051.
  Publicado: (2020)